Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11364251 Pharmaceutical formulation

Patent 11364251 was granted and assigned to Semnur Pharmaceuticals, Inc. on June, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 26 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 26 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12016867 Methods of treating inflammation and/or pain
0
Edits on 25 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 27 Mar, 2023
Edits on 27 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Mar, 2023
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 22 Jun, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 22 Jun, 2022
Edits made to:
Infobox (+20 properties)
Article (+437 characters)
‌

 US Patent 11364251 Pharmaceutical formulation

Article

Disclosed are aqueous pharmaceutical compositions which provide sustained released delivery of corticosteroid compounds. The pharmaceutical composition comprises an insoluble corticosteroid; a soluble corticosteroid; and at least one viscosity enhancing agent. Also provided are methods for using the pharmaceutical compositions in an epidural injection, intra-articular injection, intra-lesional injection, or an intra-ocular injection.

Infobox
Is a
Patent
Patent
Patent applicant
Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc.
Current assignee
Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc.
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11364251
Date of patent
June 21, 2022
Patent application number
16921628
Date Filed
July 6, 2020
Patent citations
‌
US Patent 10117938 Pharmaceutical formulation
‌
US Patent 10500284 Pharmaceutical formulation
‌
US Patent 10744144 Pharmaceutical formulation
‌
US Patent 11020485 Pharmaceutical formulation
Patent primary examiner
‌
Ali Soroush
CPC Code
‌
A61K 2300/00
‌
A61K 47/36
‌
A61K 45/06
‌
A61K 9/0019
‌
A61K 31/662
‌
A61K 31/58
‌
A61K 31/573

Find more entities like US Patent 11364251 Pharmaceutical formulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo